Swiss Re’s US CEO discusses excess mortality, long COVID and GLP-1 drugs
Mortality has become a topic of greater importance in the life insurance industry following the COVID-19 pandemic in 2020.
Mortality has become a topic of greater importance in the life insurance industry following the COVID-19 pandemic in 2020.
Will you outlive your retirement savings? What are the top five states where seniors are most likely to outlive their savings?
Here’s a framework for using artificial intelligence to build a profitable, resilient senior-market practice.
A North Carolina judge approved the release of personal policyholder information so the special master can begin getting funds to victims of Greg Lindberg’s fraud.
A Massachusetts judge accepted a recommendation Friday to dismiss a consolidated pension risk transfer complaint filed against AT&T Inc. and State Street Global Advisors last year.
As wildfires continue to drive up homeowners’ insurance premiums, California considers a transparent public catastrophe model.
The life insurance industry is at a pivotal inflection point, moving from a general approach to one of laser-focused precision.
John Hancock secret sauce behind a new strategy to boost its underwriting process? Munich Re’s rapid risk assessment platform, alitheia.
J.D. Power recently spoke with InsuranceNewsNet to discuss the findings of the latest J.D. Power U.S. Independent Agent Satisfaction Study.
The Wisconsin Office of the Commissioner of Insurance recently released a list of administrative actions for September. The actions are…
Change in the insurance business is moving ahead faster than ever.
Older Americans are aging alone, and most have not planned for household or health care assistance.
A pair of private equity-backed life insurers announced significant reinsurance deals this week with Japanese reinsurance companies.
Plaintiffs established a case that turning their pensions into Athene annuities pose a risk to their retirement earnings, the judge said Monday.
As we age, most of us will require some sort of medical treatment and it won’t be cheap.
Plaintiffs are going to court to challenge CVS Caremark’s decision to stop covering Zepbound, a weight-loss drug that is also used to treat sleep apnea.
Life’s biggest milestones bring both excitement and new financial responsibilities.
In the face of a government shutdown, investors face a familiar but unsettling question: How should they approach the markets?
October is Financial Planning Awareness Month, an opportunity for advisors to engage with existing clients and attract prospects.